{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:07:51Z","timestamp":1790633271958,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","award":["KCA-2305"],"award-info":[{"award-number":["KCA-2305"]}],"id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L251020"],"award-info":[{"award-number":["L251020"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tcm.2026.02.004","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:20:16Z","timestamp":1770312016000},"page":"412-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Septal reduction therapies for obstructive hypertrophic cardiomyopathy: Current strategies and evolving innovations"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7634-748X","authenticated-orcid":false,"given":"Hao","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartzell V.","family":"Schaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2026.02.004_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the management of hypertrophic cardiomyopathy: a report of the American heart association\/American college of cardiology joint committee on clinical practice guidelines","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0002","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2026.02.004_bib0003","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/CIRCULATIONAHA.124.072445","article-title":"Mavacamten in patients with hypertrophic cardiomyopathy referred for septal reduction: week 128 results from VALOR-HCM","volume":"151","author":"Desai","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.02.004_bib0004","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00000658-196108000-00003","article-title":"Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy","volume":"154","author":"Morrow","year":"1961","journal-title":"Ann Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jamacardio.2019.0084","article-title":"Survival differences in women and men after septal myectomy for obstructive hypertrophic cardiomyopathy","volume":"4","author":"Meghji","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","article-title":"Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy","volume":"346","author":"Sigwart","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2026.02.004_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2018.08.062","article-title":"Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a propensity score-matched cohort","volume":"157","author":"Nguyen","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0008","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.CIR.37.4.589","article-title":"Operative treatment in idiopathic hypertrophic subaortic stenosis. Techniques, and the results of preoperative and postoperative clinical and hemodynamic assessments","volume":"37","author":"Morrow","year":"1968","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.02.004_bib0009","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-5223(19)41066-0","article-title":"Hypertrophic subaortic stenosis. Operative methods utilized to relieve left ventricular outflow obstruction","volume":"76","author":"Morrow","year":"1978","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.athoracsur.2023.10.026","article-title":"Contemporary surgical management of hypertrophic cardiomyopathy","volume":"117","author":"Schaff","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0011","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jtcvs.2014.05.028","article-title":"Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy\u2014Mechanisms of obstruction and outcomes of reoperation","volume":"148","author":"Cho","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0012","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jtcvs.2016.01.051","article-title":"Excision of anomalous muscle bundles as an important addition to extended septal myectomy for treatment of left ventricular outflow tract obstruction","volume":"152","author":"Wang","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0013","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.mayocp.2019.12.001","article-title":"Septal myectomy and concomitant coronary artery bypass grafting for patients with hypertrophic cardiomyopathy and coronary artery disease","volume":"95","author":"Nguyen","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tcm.2026.02.004_bib0014","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.athoracsur.2013.07.079","article-title":"Outcome of repair of myocardial bridging at the time of septal myectomy","volume":"97","author":"Kunkala","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2020.08.066","article-title":"Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?","volume":"161","author":"Cui","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0016","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjcard.2019.09.029","article-title":"Efficacy of combined Cox-Maze IV and Ventricular Septal Myectomy for treatment of atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy","volume":"125","author":"Boll","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0017","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","article-title":"Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy","volume":"28","author":"McLeod","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2026.02.004_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2018.03.150","article-title":"Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: potential for refinement of current criteria","volume":"156","author":"Desai","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2020.12.016","article-title":"Latent outflow tract obstruction in hypertrophic cardiomyopathy: clinical characteristics and outcomes of septal myectomy","volume":"164","author":"Cui","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2019.05.053","article-title":"Conduction abnormalities and long-term mortality following septal myectomy in patients with obstructive hypertrophic cardiomyopathy","volume":"74","author":"Cui","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0021","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jtcvs.2023.04.005","article-title":"Aortic valve regurgitation following transaortic septal myectomy for obstructive hypertrophic cardiomyopathy: incidence and influence on late outcomes","volume":"168","author":"Juarez-Casso","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0022","article-title":"Changes in left atrial function, left ventricle remodeling, and fibrosis after septal myectomy for obstructive hypertrophic cardiomyopathy","author":"Tang","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.037058","article-title":"Echocardiographic changes following surgical myectomy in severely symptomatic obstructive hypertrophic cardiomyopathy: insights from the SPIRIT-HCM study","volume":"14","author":"Desai","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2026.02.004_bib0024","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.athoracsur.2022.05.062","article-title":"Impact of hospital volume on outcomes of septal myectomy for hypertrophic cardiomyopathy","volume":"114","author":"Holst","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0025","article-title":"Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes","author":"Heeringa","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2026.02.004_bib0026","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.hlc.2025.01.008","article-title":"Outcomes of septal myectomy associated with surgical volume","volume":"34","author":"Wang","year":"2025","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.tcm.2026.02.004_bib0027","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacc.2023.05.052","article-title":"First-in-Human transapical beating-heart septal myectomy in patients with hypertrophic obstructive cardiomyopathy","volume":"82","author":"Fang","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0028","first-page":"303","article-title":"Transapical septal myectomy in the beating heart via a minimally invasive approach: a feasibility study in swine","volume":"30","author":"Fang","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.124.015044","article-title":"Transapical beating-heart septal myectomy for obstructive hypertrophic cardiomyopathy: lessons learned after the learning curve period","volume":"18","author":"Fang","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2026.02.004_bib0030","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.1097\/JS9.0000000000001797","article-title":"Transapical beating heart septal myectomy learning curve and training of future surgeons: an observational study","volume":"110","author":"Li","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.tcm.2026.02.004_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012106","article-title":"Transcatheter myotomy to treat hypertrophic cardiomyopathy and enable transcatheter mitral valve replacement: first-in-human report of septal scoring along the Midline endocardium","volume":"15","author":"Greenbaum","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2026.02.004_bib0032","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011686","article-title":"Transcatheter myotomy to relieve left ventricular outflow tract obstruction: the Septal Scoring along the Midline Endocardium procedure in animals","volume":"15","author":"Khan","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2026.02.004_bib0033","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jcin.2017.01.035","article-title":"Intentional percutaneous laceration of the anterior mitral leaflet to prevent outflow obstruction during transcatheter mitral valve replacement: first-in-human experience","volume":"10","author":"Babaliaros","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2026.02.004_bib0034","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jacc.2024.02.007","article-title":"Transcatheter myotomy to reduce left ventricular outflow obstruction","volume":"83","author":"Greenbaum","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0035","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1055\/s-2008-1043055","article-title":"Catheter treatment of hypertrophic obstructive cardiomyopathy","volume":"121","author":"Gleichmann","year":"1996","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.tcm.2026.02.004_bib0036","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1161\/01.CIR.95.8.2075","article-title":"Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients: outcome in the first series of patients","volume":"95","author":"Knight","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.02.004_bib0037","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0735-1097(97)00508-1","article-title":"Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients","volume":"31","author":"Seggewiss","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0038","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.jacc.2018.09.064","article-title":"Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy","volume":"72","author":"Batzner","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0039","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jacc.2022.02.032","article-title":"Survival following alcohol septal ablation or septal myectomy for patients with obstructive hypertrophic cardiomyopathy","volume":"79","author":"Cui","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacc.2022.10.027","article-title":"Survival after septal reduction in patients >65 years old with obstructive hypertrophic cardiomyopathy","volume":"81","author":"Mentias","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0041","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13645706.2017.1378235","article-title":"Percutaneous trans-apex intra-septal radiofrequency ablation of hypertrophic cardiomyopathy","volume":"27","author":"Zuo","year":"2018","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0042","doi-asserted-by":"crossref","first-page":"e2112","DOI":"10.4244\/EIJ-D-17-00657","article-title":"Percutaneous intramyocardial septal radiofrequency ablation of hypertrophic obstructive cardiomyopathy: a novel minimally invasive treatment for reduction of outflow tract obstruction","volume":"13","author":"Liu","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.tcm.2026.02.004_bib0043","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jacc.2018.07.080","article-title":"Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy","volume":"72","author":"Liu","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0044","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamacardio.2022.0259","article-title":"Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy","volume":"7","author":"Zhou","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0045","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2010.07.055","article-title":"Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months\u2019 follow-up in 19 patients","volume":"57","author":"Lawrenz","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0046","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24217","article-title":"Short time effects of two radiofrequency ablation methods on hypertrophic obstructive cardiomyopathy","volume":"47","author":"He","year":"2024","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0047","article-title":"Comparison of percutaneous endocardial septal radiofrequency ablation with alcohol septal ablation in treating hypertrophic obstructive cardiomyopathy","author":"Tian","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.tcm.2026.02.004_bib0048","doi-asserted-by":"crossref","first-page":"oead052","DOI":"10.1093\/ehjopen\/oead052","article-title":"Septal radioablation therapy for patients with hypertrophic obstructive cardiomyopathy: first-in-human study","volume":"3","author":"Li","year":"2023","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.tcm.2026.02.004_bib0049","article-title":"Mavacamten monotherapy in real-world patients with obstructive hypertrophic cardiomyopathy: evidence from COLLIGO-HCM","author":"Bilen","year":"2025","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.tcm.2026.02.004_bib0050","article-title":"Clinical outcomes with mavacamten use in patients with obstructive hypertrophic cardiomyopathy using real-world data","author":"Patel","year":"2025","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tcm.2026.02.004_bib0051","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2026.02.004_bib0052","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa2504654","article-title":"Aficamten or metoprolol monotherapy for obstructive hypertrophic cardiomyopathy","volume":"393","author":"Garcia-Pavia","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173826000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173826000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:18:57Z","timestamp":1788866337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173826000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1050173826000228"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2026.02.004","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Septal reduction therapies for obstructive hypertrophic cardiomyopathy: Current strategies and evolving innovations","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2026.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}